Statistics
Publications
11.4K
Citations
1.1M
Authors
948
Location
Naples, Italy
11.4K
948
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy
1.7K publications · 110.7K citations
127
h-index
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy
778 publications · 34.6K citations
87
h-index
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy
899 publications · 36.2K citations
81
h-index
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy
748 publications · 27.3K citations
79
h-index
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy
627 publications · 33.1K citations
77
h-index
1–5 of 948
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2019 · 3.7K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +14
1–5 of 11.4K